Thu, Feb 20, 2020
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Hedge fund performance turns positive

Friday, July 11, 2014

Bailey McCann, Opalesque New York:

After two months of losses, hedge funds achieved gains in all strategies in May with the median fund increasing 1.01% for the month, according to the latest hedge fund monitor data from Deutsche Bank. Globally, emerging markets equity funds led the recovery gaining 1.80%; however, distressed and credit strategies continue to lead year-to-date gains at 5.74% and 4.35%, respectively. In the US, CTA / managed futures continue to recover, up 1.42% in May. In Asia, macro continues to deliver, up 2.23% for May and 1.21% year-to-date. European performance continues to be led by credit and event strategies, both up over 3% for the year. Global dispersion of returns was highest for CTA / managed futures, emerging markets equity and macro strategies.

The MSCI World 30-day volatility decreased by 38.11% over the month, ending at 5.52 on 27 May 2014. Both gross and net fundamental equity exposure also decreased last month ending at 2.64 (-2.26%) and 0.70 (-2.00%) respectively.

Though M&A was less noteworthy than previous months, convertible bond deals in Europe picked-up totaling €1.48 billion in May. In the US, short sellers focused on biotech firms Medivation and Pharmacyclics. The sales tax increase in Japan resulted in record high inflation and a decline in sales that garnered short interest for the retail sector. In China, banks experienced the largest quarterly increase in bad loans since 2005 bringing attention to Minsheng Bank and ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. PE/VC: Venture debt: Is it a loan? Is it equity? Is it an pportunity?, PE, VC investments in India hit all-time high in 2019[more]

    Venture debt: Is it a loan? Is it equity? Is it an pportunity? From Forbes: Venture Capital is usually the default option for fast-growth startups looking for a cash injection, thanks to our willingness to take risks in return for equity, and with no need to pay anything back - at least

  2. Other Voices: Evolution of shrinking hedge fund fees - what do investors and managers need to know?[more]

    By Don Steinbrugge, Founder and CEO, Agecroft Partners (DonSteinbrugge@agecroftpartners.com): Hedge funds fees remain under extreme pressure across the industry. This strong trend is driven by declining return expectations from investors, inc

  3. COVID-19: Investors track ships, chase rumours to get edge on COVID-19 risks, Coronavirus risk puts the bull run on pause, China was wise to let markets stumble[more]

    Investors track ships, chase rumours to get edge on COVID-19 risks From Reuters: As investors crunch numbers to determine how the coronavirus will hit China's economy, hedge fund manager Nathaniel Polachek has tied much of his outlook to the fate of a ship anchored near Weihai, China.

  4. Bruce Berkowitz is back!, Coatue's new quant fund lost money in the fourth quarter[more]

    Bruce Berkowitz is back! From Institutional Investor: Famed value investor Bruce Berkowitz has hit hard times over the past decade, with big bets on losers like Eddie Lampert's Sears Holdings. In fact, over the past 10 years, his Fairholme Fund's annualized return is only 4.89 percent -

  5. Opalesque Exclusive: Optima A.M. bets on healthcare and biotech innovations with long/short strategy[more]

    B. G., Opalesque Geneva: Optima Asset Management has just launched the Optima Healthcare and Biotechnology strategy, which will be managed by five portfolio managers